Bioventus Inc. (BVS)
NASDAQ: BVS · Real-Time Price · USD
13.96
-0.17 (-1.20%)
At close: Aug 10, 2026, 4:00 PM EDT
13.99
+0.03 (0.21%)
After-hours: Aug 10, 2026, 7:34 PM EDT
Bioventus Employees
Bioventus had 940 employees as of March 28, 2026. The number of employees increased by 10 or 1.08% since the number was last reported on December 31, 2025.
Employees
940
Change
10
Growth
1.08%
Revenue / Employee
$618,987
Profits / Employee
$57,940
Market Cap
1.17B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Mar 28, 2026 | 940 | 10 | 1.08% |
| Dec 31, 2025 | 930 | 0 | - |
| Dec 31, 2024 | 930 | -40 | -4.12% |
| Dec 31, 2023 | 970 | -150 | -13.39% |
| Dec 31, 2022 | 1,120 | -80 | -6.67% |
| Dec 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Enovis | 7,802 |
| QuidelOrtho | 6,500 |
| Integra LifeSciences Holdings | 4,427 |
| CONMED | 3,900 |
| Tandem Diabetes Care | 2,500 |
| Artivion | 1,800 |
| Alphatec Holdings | 913 |
| PROCEPT BioRobotics | 888 |
BVS News
- 4 days ago - Bioventus price target raised to $18 from $16 at Craig-Hallum - TheFly
- 4 days ago - Bioventus price target raised to $18 from $14 at Barrington - TheFly
- 5 days ago - Bioventus reports Q2 EPS 22c, consensus 22c - TheFly
- 5 days ago - Bioventus backs FY26 adjusted EPS view 75c-79c, consensus 78c - TheFly
- 5 days ago - Bioventus initiates review of strategic alternatives - TheFly
- 5 days ago - Bioventus Earnings Call Transcript: Q2 2026 - Transcripts
- 5 days ago - Bioventus Earnings release: Q2 2026 - Filings
- 5 days ago - Bioventus Quarterly report: Q2 2026 - Filings